0001596771-18-000009.txt : 20180130
0001596771-18-000009.hdr.sgml : 20180130
20180130160631
ACCESSION NUMBER: 0001596771-18-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180129
FILED AS OF DATE: 20180130
DATE AS OF CHANGE: 20180130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gullans Steven R. Ph.D.
CENTRAL INDEX KEY: 0001571997
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 18559162
MAIL ADDRESS:
STREET 1: C/O EXCEL VENTURE MANAGEMENT, LLC
STREET 2: 800 BOYLSTON ST., STE 2825
CITY: BOSTON
STATE: MA
ZIP: 02199
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gemphire Therapeutics Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
BUSINESS PHONE: 248-980-6538
MAIL ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-01-29
0
0001638287
Gemphire Therapeutics Inc.
GEMP
0001571997
Gullans Steven R. Ph.D.
17199 N. LAUREL PARK DRIVE
SUITE 401
LIVONIA
MI
48152
1
1
0
0
Interim President & CEO
Employee Stock Option (right to buy)
10.44
2018-01-29
4
A
0
60000
0
A
2028-01-28
Common Stock
60000
60000
D
The option vests in 12 equal consecutive monthly installments on the last day of each month, commencing on the grant date, subject to acceleration upon the appointment of a permanent President and Chief Executive Officer.
/s/ Stephanie Swan, by Power of Attorney
2018-01-30